Should Screening for Prostate Cancer Be Routinely Practised in 1997? the Argument Against

Miller B A Ries L A Hankey B F SEER Cancer Statistics Review: 1973–1990. NIH Publication No 93–2789, 1993.

Coleman M P Esteve J Damiecki P Arslan A Renard H . Trends in cancer incidence and mortality. IARC Scientific Publications, 1993.

Potosky A L Miller B A Albertsen P C Kramer B S The role of increasing detection in the rising incidence of prostate cancer. Journal of the American Medical Association 1995;273: 548–552.

Fleming C Wasson J H Albertsen P C Barry M J Wennberg J E (Prostate Patient Outcomes Research Team). A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Journal of the American Medical Association 1993;269: 2650–2658.

Bostwick D G The pathology of incidental carcinoma. Cancer Surveys 1995;23: 7–18.

Crissman J D Sakr W A Hussein M E Pontes J E DNA quantitation of intraepithelial neoplasia and invasive carcinoma of the prostate. Prostate 1993;22: 155–162.

Isaacs W B Bova G S Morton R A Bussemakers M J Brooks J D Ewing C M Molecular biology of prostate cancer progression. Cancer Surveys 1995;23: 19–32.

Bostwick D G Graham S D Jr. Napalkov P Staging of early prostate cancer: A proposed tumor volume-based prognostic index. Urology 1993;41: 403–411.

McNeal J E Kindrachuk R A Freiha F S Bostwick D G Redwine E A Stamey T A Patterns of progression in prostate cancer. The Lancet 1986;i: 60–63.

Johansson J Andersson S Krusemo U B Adami H Bergstrom R Kraaz W . Natural history of localised prostate cancer. The Lancet 1989;i: 799–803.

Sakr W A Grignon D J Haas G P Epidemiology of high grade prostatic intraepithelial neoplasia. Pathology, Research & Practice 1995;191: 838–841.

von Eschenbach A C The biologic dilemma of early carcinoma of the prostate. Cancer 1996;78: 326–329.

Schmid H P Tumour markers in patients on deferred treatment: Prostate specific antigen doubling times. Cancer Surveys 1995;23: 157–167.

George N J R Natural history of localised prostatic cancer managed by conservative therapy alone. The Lancet 1988;i: 494–496.

Johansson J E Expectant management of early stage prostatic cancer: Swedish experience. Journal of Urology 1994;152: 1753–1756.

Parkes C A An epidemiologist's viewpoint on screening. Cancer Surveys 1995;23: 127–140.

Robey E L Schellhammer P F Local failure after definitive therapy for prostate cancer. Journal of Urology 1987;137: 613–619.

Lerner S E Seay T M Blute M L Bergstralh E J Barrett D Zincke H . Prostate specific antigen detected prostate cancer (clinical stage Tic): An interim analysis. Journal of Urology 1996;155: 821–826.

Hanks G E Martz K L Diamond JJ The effect of dose on local control of prostate cancer. International Journal of Radiation Oncology, Biology, Physics 1988;15: 1299–1305.

Zagars G K Pollack A von Eschenbach A C Prostate cancer and radiation therapy — The message conveyed by serum prostate-specific antigen. International Journal of Radiation Oncology, Biology, Physics 1995;33: 23–35.

Epstein J I Walsh P C Brendler C B Radical prostatectomy for impalpable prostate cancer: The Johns Hopkins experience with tumors found on transurethral resection (stages T1A and T1B) and on needle biopsy (stage T1C). Journal Urology 1994;152: 1721–1729.

Dugan J A Bostwick D G Myers R P Qian J Bergstralh E J Oesterling J E The definition and preoperative prediction of clinically insignificant prostate cancer. Journal of the American Medical Association 1996;275: 288–294.

Humphrey P A Keetch D W Smith D S Shepherd D L Catalona W J Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening. Journal of Urology 1996;155: 816–820.

Helgesen F Holmberg L Johansson J E Bergstrom R Adami H O Trends in prostate cancer survival in Sweden, 1960 through 1988: Evidence of increasing diagnosis of nonlethal tumors. Journal of the National Cancer Institute 1996;88: 1216–1221.

Chodak G . Prostate cancer: To screen or not to screen. Acta Oncologica 1991;30: 285–287.

Denis L J Prostate cancer screening and prevention: ‘realities and hope’. Urology 1995;46: 56–61.

Hall R R Screening and early detection of prostate cancer will decrease morbidity and mortality from prostate cancer: The argument against. European Urology 1996;29: 24–26.

McCaul K A Luke C G Roder D M Trends in prostate cancer incidence and mortality rates in South Australia, 1977–1993. Medical Journal of Australia 1995;162: 520–522.